Skip to main content

Amarna Therapeutics B.V.

  • | Biotech or pharma, therapeutic R&D
Amarna Therapeutics B.V.
Amarna Therapeutics is a pre-clinical biotech company that has developed a unique, non-immunogenic viral platform named Nimvec™, derived from the macaque polyomavirus simian virus 40 (SV40) that allows repeated dosing.

Address

Leiden
Netherlands
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors